Biological characterization of a novel class of toll-like receptor 7 agonists designed to have reduced systemic activity-Reference-Cited by-同舟云学术

Biological characterization of a novel class of toll-like receptor 7 agonists designed to have reduced systemic activity

Published:2012-04-13 Issue:2 Volume:166 Page:573-586
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Biffen M,Matsui H,Edwards S,Leishman AJ,Eiho K,Holness E,Satterthwaite G,Doyle I,Wada H,Fraser NJ,Hawkins SL,Aoki M,Tomizawa H,Benjamin AD,Takaku H,McInally T,Murray CM

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.2011.01790.x/fullpdf

Reference34 articles.

1. Guide to Receptors and Channels (GRAC), 5th Edition;Alexander;Br J Pharmacol,2011

2. Environmental exposure to endotoxin and its relation to asthma in school-age children;Braun-Fahrlander;N Engl J Med,2002

3. Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463;Camateros;Am J Respir Crit Care Med,2007

4. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA;Diebold;Science,2004

5. First in human phase I trial of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced cancer;Dudek;Clin Cancer Res,2007

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Optimization of 1-Substituted Imidazo[4,5-c]quinoline TLR7 Agonists;ACS Medicinal Chemistry Letters;2023-09-14

2. Chemical reagents modulate nucleic acid-activated toll-like receptors;Biomedicine & Pharmacotherapy;2022-03

3. Targeted Rejuvenation of Exhausted Chimeric Antigen Receptor T Cells Regresses Refractory Solid Tumors;Molecular Cancer Research;2022-02-08

4. Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants;Advanced Drug Delivery Reviews;2021-08

5. In Vitro Characterization of the Innate Immune Pathways Engaged by Live and Inactivated Tick-Borne Encephalitis Virus;Vaccines;2021-06-17